Sun Pharmaceutical Industries Limited (BOM:524715)

BOM:524715 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,920,993	4,162,126	3,888,242	2,358,729	2,194,737	1,434,322
Market Cap Growth	-11.54%	7.04%	64.84%	7.47%	53.02%	69.69%
Enterprise Value	3,697,409	3,989,271	3,792,904	2,296,495	2,136,376	1,424,670
Last Close Price	1634.40	1729.76	1600.44	962.03	885.61	572.49
PE Ratio	37.52	38.08	40.60	27.84	67.06	49.39
PS Ratio	7.13	7.92	8.02	5.38	5.68	4.28
PB Ratio	5.02	5.74	5.79	3.98	4.30	2.90
P/TBV Ratio	7.15	7.67	8.39	6.16	6.23	4.16
P/FCF Ratio	44.89	34.85	39.14	82.08	29.30	28.69
P/OCF Ratio	31.23	29.58	32.04	47.56	24.43	23.25
EV/Sales Ratio	6.73	7.59	7.82	5.23	5.53	4.25
EV/EBITDA Ratio	23.43	26.65	29.46	19.71	21.04	17.07
EV/EBIT Ratio	28.17	31.65	36.05	24.68	26.19	22.17
EV/FCF Ratio	42.33	33.40	38.18	79.91	28.53	28.49
Debt / Equity Ratio	0.07	0.03	0.05	0.12	0.03	0.08
Debt / EBITDA Ratio	0.33	0.16	0.25	0.58	0.13	0.46
Debt / FCF Ratio	0.60	0.20	0.33	2.40	0.17	0.77
Asset Turnover	0.57	0.59	0.58	0.58	0.56	0.49
Inventory Turnover	1.18	1.10	1.08	1.12	1.17	1.05
Quick Ratio	1.85	2.17	1.82	1.36	1.37	1.20
Current Ratio	2.57	2.89	2.56	2.00	2.03	1.89
Return on Equity (ROE)	14.22%	15.71%	15.20%	15.43%	6.74%	4.61%
Return on Assets (ROA)	8.57%	8.87%	7.91%	7.73%	7.42%	5.91%
Return on Invested Capital (ROIC)	18.86%	20.12%	17.87%	18.65%	14.83%	11.61%
Return on Capital Employed (ROCE)	16.40%	17.10%	15.40%	15.30%	15.50%	12.50%
Earnings Yield	2.67%	2.63%	2.46%	3.59%	1.49%	2.02%
FCF Yield	2.23%	2.87%	2.56%	1.22%	3.41%	3.49%
Dividend Yield	0.98%	0.92%	0.84%	1.20%	1.13%	1.31%
Payout Ratio	35.73%	33.07%	30.26%	29.73%	65.97%	53.70%
Buyback Yield / Dilution	-0.11%	-	-	-	-	-
Total Shareholder Return	0.87%	0.92%	0.84%	1.20%	1.13%	1.31%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.